Position paper of the Italian League against Epilepsy
The ozempic segment dominated the market in 2025 with 32.15% share
Belle Review: Outstanding Support, Troubled Pharmacy Partners Our review team placed a real order at Belle, experienced the full intake-to-delivery flow as patients, and graded everything through our True Value Score framework
GLP-1 Multi-District Litigation | Updates And What You Need To Know Jun 28, 2025 4 min read The wave of lawsuits involving GLP-1 receptor agonistssuch as Ozempic, Wegovy, Trulicity, and Mounjarohas evolved into one of the most closely watched mass torts in the country
From a system perspective, increased use of these medications may help reduce long-term healthcare costs by preventing or mitigating expensive chronic diseases
Adolescents and young adults are increasingly using GLP-1 receptor agonists for weight management, raising concerns among some dermatologists who may also prescribe a teratogenic drug like isotretinoin for acne